A. Decherf

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Saccharomyces boulardii in Infants and Children With Acute Diarrhea

Parthiv Shah, D. Parikh, M. Satia, 2020, The Pediatric infectious disease journal.

Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis.

P. Mosci, A. Vecchiarelli, E. Roselletti, 2018, Beneficial microbes.

Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation

P. Desreumaux, S. Legrain-Raspaud, M. Clément-Ziza, 2022, World journal of gastroenterology.

Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration

S. Legrain-Raspaud, Mickaël Boyer, M. Clément-Ziza, 2020, Nutrients.

Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis

S. Bozza, B. Camilloni, A. Vecchiarelli, 2020, Microorganisms.

Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis

P. Mosci, A. Vecchiarelli, S. Sabbatini, 2018, Virulence.

The probiotic strain Bacillus subtilis CU1 primes antimicrobial innate immune response and reduces low-grade inflammation: a clinical study.

M. Porbahaie, A. Decherf, F. Mourey, 2024, Beneficial microbes.